Multimodal radiomics-based methods using deep learning for prediction of brain metastasis in non-small cell lung cancer with 18F-FDG PET/CT images

被引:0
|
作者
Zhu, Yuan [1 ,2 ]
Cong, Shan [2 ]
Zhang, Qiyang [1 ]
Huang, Zhenxing [1 ]
Yao, Xiaohui [2 ]
Cheng, You [3 ]
Liang, Dong [1 ,4 ]
Hu, Zhanli [1 ,4 ]
Shao, Dan [3 ]
机构
[1] Chinese Acad Sci, Shenzhen Inst Adv Technol, Lauterbur Rese Ctr Biomed Imaging, Shenzhen 518055, Peoples R China
[2] Harbin Engn Univ, Qingdao Innovat & Dev Ctr, Qingdao 266000, Peoples R China
[3] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Nucl Med, Guangzhou, Peoples R China
[4] Chinese Acad Sci, Key Lab Biomed Imaging Sci & Syst, Shenzhen 518055, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
brain metastasis; non-small cell lung cancer; 18F-PET/CT; radiomics; deep learning; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; MANAGEMENT; RECURRENT; SYSTEM;
D O I
10.1088/2057-1976/ad7595
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective. Approximately 57% of non-small cell lung cancer (NSCLC) patients face a 20% risk of brain metastases (BMs). The delivery of drugs to the central nervous system is challenging because of the blood-brain barrier, leading to a relatively poor prognosis for patients with BMs. Therefore, early detection and treatment of BMs are highly important for improving patient prognosis. This study aimed to investigate the feasibility of a multimodal radiomics-based method using 3D neural networks trained on F-18-FDG PET/CT images to predict BMs in NSCLC patients. Approach. We included 226 NSCLC patients who underwent F-18-FDG PET/CT scans of areas, including the lung and brain, prior to EGFR-TKI therapy. Moreover, clinical data (age, sex, stage, etc) were collected and analyzed. Shallow lung features and deep lung-brain features were extracted using PyRadiomics and 3D neural networks, respectively. A support vector machine (SVM) was used to predict BMs. The receiver operating characteristic (ROC) curve and F1 score were used to assess BM prediction performance. Main result. The combination of shallow lung and shallow-deep lung-brain features demonstrated superior predictive performance (AUC = 0.96 +/- 0.01). Shallow-deep lung-brain features exhibited strong significance (P < 0.001) and potential predictive performance (coefficient > 0.8). Moreover, BM prediction by age was significant (P < 0.05). Significance. Our approach enables the quantitative assessment of medical images and a deeper understanding of both superficial and deep tumor characteristics. This noninvasive method has the potential to identify BM-related features with statistical significance, thereby aiding in the development of targeted treatment plans for NSCLC patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and 18F-FDG PET/CT Radiomics
    Ju, Hyemin
    Kim, Kangsan
    Kim, Byung Il
    Woo, Sang-Keun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [42] Construction of a prognostic risk score model with multimodal features of 18F-FDG PET/CT images of non-small cell lung cancer byfeatures fusing
    Wang, X.
    Li, X.
    Cui, C.
    Wu, Z.
    Wu, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S725 - S726
  • [43] Predictive value of 18F-FDG PET/CT metabolic parameters for lymph node metastasis of non-small cell lung cancer
    Yu, Xiaopeng
    Wang, Jianlin
    Huang, Liqun
    Xie, Long
    Su, Yingrui
    BIOMARKERS IN MEDICINE, 2025, 19 (02) : 35 - 41
  • [44] Impact of 18F-FDG PET/CT on Initial Staging of Non-small Cell Lung Cancer in Thailand
    Promteangtrong, C.
    Kunawudhi, A.
    Phadungrerk, R.
    Iamsa-art, C.
    Chotipanich, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S480 - S481
  • [45] Prognostic Significance of Metabolic Parameters by 18F-FDG PET/CT in Non-Small Cell Lung Cancer
    Eren, G.
    Asa, S.
    Kupik, O.
    Gungor, S.
    Asa, S. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S233 - S233
  • [46] Comparison of 18F-FDG PET/CT and MDCT for staging/restaging of non-small cell lung cancer
    Sobic-Saranovic, D.
    Petrusic, I.
    Artiko, V.
    Pavlovic, S.
    Subotic, D.
    Saranovic, D.
    Nagorni-Obradovic, L.
    Petrovic, N.
    Todorovic-Tirnanic, M.
    Odalovic, S.
    Grozdic-Milojevic, I.
    Stoiljkovic, M.
    Obradovic, V.
    NEOPLASMA, 2015, 62 (02) : 295 - 301
  • [47] Prognostic value of 18F-FDG PET/CT quantitative metrics in non-small cell lung cancer
    Fontao de Castro, S.
    Prospero, I.
    Violante, L. S.
    Ferreira, G.
    Teixeiro, J.
    Duarte, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S83 - S84
  • [48] Role of 18F-FDG PET/CT in radiotherapy planning for patients with non-small cell lung cancer
    Garcia-Talavera, P.
    Matias-Perez, A.
    Cigarrol, C.
    Gomez-Caminero, F.
    Perez-Romasanta, L. A.
    Martin, M. E.
    Martin, E.
    Perez, B.
    Tamayo, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S485 - S485
  • [49] Comparison of 18F-FDG PET/CT and MDCT for Detection Metastases of Non-Small Cell Lung Cancer
    Sobic-Saranovic, D.
    Petrusic, I.
    Artiko, V.
    Kozarevic, N.
    Odalovic, S.
    Grozdic-Milojevic, I.
    Stoiljkovic, M.
    Obradovic, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S485 - S485
  • [50] Segmentation in Non-Small Cell Lung Tumors Using 18F-FDG PET/CT Tips and Rules
    Jimenez Londono, German Andres
    Perez-Beteta, Julian
    Bosque, Jesus J.
    Honguero-Martinez, Antonio Fancisco
    Garcia Vicente, Ana Maria
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (11) : E477 - E482